Home Featured Page 145

Featured

Latest

Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M

Q3’25 Psychedelic Lobbying Update

Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher

The Psychedelic News Feed: October 20 – 26, 2025

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed

Small Pharma to Participate in Upcoming September Investor Conferences

Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of...

Psyence Group Announces Amendment and Closing of Previously Announced Private Placement

atai Life Sciences to Participate in September Investor Events

Mindset Pharma Files National Patents Protecting Family 1 Application in 16...

BetterLife and Collaborators to Submit Key Joint Research Publication

Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida...

MindMed to Participate in H.C. Wainwright Global Investment ConferenceUSA – EnglishUSA...

PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™...

1...144145146...300 Page 145 of 300

Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants...

Q3’25 Psychedelic Lobbying Update

Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M

Q3’25 Psychedelic Lobbying Update

Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher

The Psychedelic News Feed: October 20 – 26, 2025

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed

Small Pharma to Participate in Upcoming September Investor Conferences

Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of...

Psyence Group Announces Amendment and Closing of Previously Announced Private Placement

atai Life Sciences to Participate in September Investor Events

Mindset Pharma Files National Patents Protecting Family 1 Application in 16...

BetterLife and Collaborators to Submit Key Joint Research Publication

Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida...

MindMed to Participate in H.C. Wainwright Global Investment ConferenceUSA – EnglishUSA...

PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™...

EDITOR PICKS

Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants...

Q3’25 Psychedelic Lobbying Update

Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY